PseudoSimulationsSummary-class | R Documentation |
Note that objects should not be created by users, therefore no initialization function is provided for this class.
targetEndOfTrial
the target probability of DLE wanted at the end of a trial
targetDoseEndOfTrial
the dose level corresponds to the target probability of DLE wanted at the end of a trial, TDEOT
targetDoseEndOfTrialAtDoseGrid
the dose level at dose grid corresponds to the target probability of DLE wanted at the end of a trial
targetDuringTrial
the target probability of DLE wanted during a trial
targetDoseDuringTrial
the dose level corresponds to the target probability of DLE wanted during the trial. TDDT
targetDoseDuringTrialAtDoseGrid
the dose level at dose grid corresponds to the target probability of DLE wanted during a trial
TDEOTSummary
the six-number table summary, include the lowest, the 25th precentile (lower quatile), the 50th percentile (median), the mean, the 27th percentile and the highest values of the final dose levels obtained corresponds to the target probability of DLE want at the end of a trial across all simulations
TDDTSummary
the six-number table summary, include the lowest, the 25th precentile (lower quatile), the 50th percentile (median), the mean, the 27th percentile and the highest values of the final dose levels obtained corresponds to the target probability of DLE want during a trial across all simulations
FinalDoseRecSummary
the six-number table summary, include the lowest, the 25th precentile (lower quatile), the 50th percentile (median), the mean, the 27th percentile and the highest values of the final optimal doses, which is either the TDEOT when only DLE response are incorporated into the escalation procedure or the minimum of the TDEOT and Gstar when DLE and efficacy responses are incorporated, across all simulations
ratioTDEOTSummary
the six-number summary table of the final ratios of the upper to the lower 95% credibility intervals of the final TDEOTs across all simulations
FinalRatioSummary
the six-number summary table of the final ratios of the upper to the lower 95% credibility intervals of the final optimal doses across all simulations #@slot doseRec the dose level that will be recommend for subsequent study
nsim
number of simulations
propDLE
proportions of DLE in the trials
meanToxRisk
mean toxicity risks for the patients
doseSelected
doses selected as MTD (targetDoseEndOfTrial)
toxAtDosesSelected
true toxicity at doses selected
propAtTargetEndOfTrial
Proportion of trials selecting at the doseGrid closest below the MTD, the targetDoseEndOfTrial
propAtTargetDuringTrial
Proportion of trials selecting at the doseGrid closest below the targetDoseDuringTrial
doseMostSelected
dose most often selected as MTD
obsToxRateAtDoseMostSelected
observed toxicity rate at dose most often selected
nObs
number of patients overall
nAboveTargetEndOfTrial
number of patients treated above targetDoseEndOfTrial
nAboveTargetDuringTrial
number of patients treated above targetDoseDuringTrial
doseGrid
the dose grid that has been used
fitAtDoseMostSelected
fitted toxicity rate at dose most often selected
meanFit
list with the average, lower (2.5 quantiles of the mean fitted toxicity at each dose level
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.